ABBVON

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

Meno ABBVON

Pozícia No.3317

Trhová kapitalizácia $0.00

Plne zriedená trhová hodnota $0.00

Podiel na trhu %

Objem obchodovania/trhová kapitalizácia (24 h) 960,454.06%

Počet coinov v obehu 123.08541488

Max. počet coinov v obehu 0

Celková ponuka 123.08541488

Rýchlosť obehu %

Dátum vydania --

Cena, za ktorú bolo aktívum prvýkrát vydané --

Celkové maximum 237.64005999136555, 2026-03-05

Najnižšia cena 193.3720963640878, 2026-04-29

Verejný blockchain ABBVON

Úvod AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

Sektor

Sociálne siete

• Twitter

• Oficiálna webová stránka
• Prieskumník blokov

Analýza toku finančných prostriedkov

etfindex:mc_etfindex_source Odmietnutie zodpovednosti: Údaje, ktoré poskytuje cmc a ktoré by sa nemali považovať za investičné poradenstvo.